CLINICAL RESEARCH: CARDIAC IMAGING
In Vivo 18F-Fluorodeoxyglucose Positron Emission Tomography Imaging Provides a Noninvasive Measure of Carotid Plaque Inflammation in Patients
Ahmed Tawakol, MD*,*,
Raymond Q. Migrino, MD ,
Gregory G. Bashian, MD*,
Shahinaz Bedri, MBBS ,
David Vermylen, BA*,
Ricardo C. Cury, MD ,
Denise Yates, PhD ,
Glenn M. LaMuraglia, MD||,
Karen Furie, MD ,
Stuart Houser, MD ,
Henry Gewirtz, MD*,
James E. Muller, MD*,
Thomas J. Brady, MD and
Alan J. Fischman, MD, PhD
* Departments of Medicine (Cardiac Unit)
Radiology and Nuclear Medicine
Pathology
Neurology
|| Division of Vascular and Endovascular Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
Manuscript received July 27, 2005;
revised manuscript received April 27, 2006,
accepted May 2, 2006.
* Reprint requests and correspondence: Dr. Ahmed Tawakol, Cardiac Unit/YAW 5904, Massachusetts General Hospital, Boston, Massachusetts 02114. (Email: atawakol{at}partners.org).
OBJECTIVES: Given the importance of inflammation in atherosclerosis, we sought to determine if atherosclerotic plaque inflammation could be measured noninvasively in humans using positron emission tomography (PET).
BACKGROUND: Earlier PET studies using fluorodeoxyglucose (FDG) demonstrated increased FDG uptake in atherosclerotic plaques. Here we tested the ability of FDG-PET to measure carotid plaque inflammation in patients who subsequently underwent carotid endarterectomy (CEA).
METHODS: Seventeen patients with severe carotid stenoses underwent FDG-PET imaging 3 h after FDG administration (13 to 25 mCi), after which carotid plaque FDG uptake was determined as the ratio of plaque to blood activity (target to background ratio, TBR). Less than 1 month after imaging, subjects underwent CEA, after which carotid specimens were processed to identify macrophages (staining with anti-CD68 antibodies).
RESULTS: There was a significant correlation between the PET signal from the carotid plaques and the macrophage staining from the corresponding histologic sections (r = 0.70; p < 0.0001). When mean FDG uptake (mean TBR) was compared with mean inflammation (mean percentage CD68 staining) for each of the 17 patients, the correlation was even stronger (r = 0.85; p < 0.0001). Fluorodeoxyglucose uptake did not correlate with plaque area, plaque thickness, or area of smooth muscle cell staining.
CONCLUSIONS: We established that FDG-PET imaging can be used to assess the severity of inflammation in carotid plaques in patients. If subsequent natural history studies link increased FDG-PET activity in carotid arteries with clinical events, this noninvasive measure could be used to identify a subset of patients with carotid atherosclerosis in need of intensified medical therapy or carotid artery intervention to prevent stroke.
|
Abbreviations and Acronyms
| | CEA = carotid endarterectomy | | FDG = 18F-fluorodeoxyglucose | | hsCRP = high-sensitivity C-reactive protein | | PET = positron emission tomography | | SUV = standardized uptake value | | TBR = target-to-background ratio |
|
Related Article
-
Simvastatin Attenuates Plaque Inflammation: Evaluation by Fluorodeoxyglucose Positron Emission Tomography
- Nobuhiro Tahara, Hisashi Kai, Masatoshi Ishibashi, Hiroyuki Nakaura, Hayato Kaida, Kenkichi Baba, Naofumi Hayabuchi, and Tsutomu Imaizumi
J. Am. Coll. Cardiol. 2006 48: 1825-1831.
[Abstract]
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
C. M. Matter, M. Stuber, and M. Nahrendorf
Imaging of the unstable plaque: how far have we got?
Eur. Heart J.,
November 1, 2009;
30(21):
2566 - 2574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nahrendorf, E. Keliher, P. Panizzi, H. Zhang, S. Hembrador, J.-L. Figueiredo, E. Aikawa, K. Kelly, P. Libby, and R. Weissleder
18F-4V for PET-CT Imaging of VCAM-1 Expression in Atherosclerosis
J. Am. Coll. Cardiol. Img.,
October 1, 2009;
2(10):
1213 - 1222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rominger, T. Saam, S. Wolpers, C. C. Cyran, M. Schmidt, S. Foerster, K. Nikolaou, M. F. Reiser, P. Bartenstein, and M. Hacker
18F-FDG PET/CT Identifies Patients at Risk for Future Vascular Events in an Otherwise Asymptomatic Cohort with Neoplastic Disease
J. Nucl. Med.,
October 1, 2009;
50(10):
1611 - 1620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Mahmood
Science to Practice: Can an Enzyme-sensitive MR Contrast Agent Be Used to Image Inflammation in Aneurysms?
Radiology,
September 1, 2009;
252(3):
627 - 628.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H.F. Rudd, M. Elkhawad, and Z. A. Fayad
Vascular Imaging with 18F-FDG PET/CT: Optimal 18F-FDG Circulation Time?
J. Nucl. Med.,
September 1, 2009;
50(9):
1560 - 1560.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Saraste, S. G. Nekolla, and M. Schwaiger
Cardiovascular molecular imaging: an overview
Cardiovasc Res,
September 1, 2009;
83(4):
643 - 652.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Choudhury and E. A. Fisher
Molecular Imaging in Atherosclerosis, Thrombosis, and Vascular Inflammation
Arterioscler Thromb Vasc Biol,
July 1, 2009;
29(7):
983 - 991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Laitinen, A. Saraste, E. Weidl, T. Poethko, A. W. Weber, S. G. Nekolla, P. Leppanen, S. Yla-Herttuala, G. Holzlwimmer, A. Walch, et al.
Evaluation of {alpha}v{beta}3 Integrin-Targeted Positron Emission Tomography Tracer 18F-Galacto-RGD for Imaging of Vascular Inflammation in Atherosclerotic Mice
Circ Cardiovasc Imaging,
July 1, 2009;
2(4):
331 - 338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H.F. Rudd, F. Hyafil, and Z. A. Fayad
Inflammation Imaging in Atherosclerosis
Arterioscler Thromb Vasc Biol,
July 1, 2009;
29(7):
1009 - 1016.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Menezes, C. W. Kotze, B. F. Hutton, R. Endozo, J. C. Dickson, I. Cullum, S. W. Yusuf, P. J. Ell, and A. M. Groves
Vascular Inflammation Imaging with 18F-FDG PET/CT: When to Image?
J. Nucl. Med.,
June 1, 2009;
50(6):
854 - 857.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Hyafil, J.-C. Cornily, J. H.F. Rudd, J. Machac, L. J. Feldman, and Z. A. Fayad
Quantification of Inflammation Within Rabbit Atherosclerotic Plaques Using the Macrophage-Specific CT Contrast Agent N1177: A Comparison with 18F-FDG PET/CT and Histology
J. Nucl. Med.,
June 1, 2009;
50(6):
959 - 965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Fox and H. W. Strauss
One Step Closer to Imaging Vulnerable Plaque in the Coronary Arteries
J. Nucl. Med.,
April 1, 2009;
50(4):
497 - 500.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Tahara, T. Imaizumi, R. Virmani, and J. Narula
Clinical Feasibility of Molecular Imaging of Plaque Inflammation in Atherosclerosis
J. Nucl. Med.,
March 1, 2009;
50(3):
331 - 334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H.F. Rudd, K. S. Myers, S. Bansilal, J. Machac, M. Woodward, V. Fuster, M. E. Farkouh, and Z. A. Fayad
Relationships Among Regional Arterial Inflammation, Calcification, Risk Factors, and Biomarkers: A Prospective Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Imaging Study
Circ Cardiovasc Imaging,
March 1, 2009;
2(2):
107 - 115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Falk, T. Thim, and I. B. Kristensen
Atherosclerotic plaque, adventitia, perivascular fat, and carotid imaging.
J. Am. Coll. Cardiol. Img.,
February 1, 2009;
2(2):
183 - 186.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nahrendorf, D. E. Sosnovik, B. A. French, F. K. Swirski, F. Bengel, M. M. Sadeghi, J. R. Lindner, J. C. Wu, D. L. Kraitchman, Z. A. Fayad, et al.
Multimodality Cardiovascular Molecular Imaging, Part II
Circ Cardiovasc Imaging,
January 1, 2009;
2(1):
56 - 70.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Izquierdo-Garcia, J. R. Davies, M. J. Graves, J. H.F. Rudd, J. H. Gillard, P. L. Weissberg, T. D. Fryer, and E. A. Warburton
Comparison of Methods for Magnetic Resonance-Guided [18-F]Fluorodeoxyglucose Positron Emission Tomography in Human Carotid Arteries: Reproducibility, Partial Volume Correction, and Correlation Between Methods
Stroke,
January 1, 2009;
40(1):
86 - 93.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Yoshida, S. Borkar, B. Singh, R. A. Ghossein, and H. Schoder
Incidental Detection of Concurrent Extramedullary Plasmacytoma and Amyloidoma of the Nasopharynx on [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
J. Clin. Oncol.,
December 10, 2008;
26(35):
5817 - 5819.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Lee, Y. K. On, E. J. Lee, J. Y. Choi, B.-T. Kim, and K.-H. Lee
Reversal of Vascular 18F-FDG Uptake with Plasma High-Density Lipoprotein Elevation by Atherogenic Risk Reduction
J. Nucl. Med.,
August 1, 2008;
49(8):
1277 - 1282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Flogel, Z. Ding, H. Hardung, S. Jander, G. Reichmann, C. Jacoby, R. Schubert, and J. Schrader
In Vivo Monitoring of Inflammation After Cardiac and Cerebral Ischemia by Fluorine Magnetic Resonance Imaging
Circulation,
July 8, 2008;
118(2):
140 - 148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Kwee, R. J. van Oostenbrugge, L. Hofstra, G. J. Teule, J.M.A. van Engelshoven, W. H. Mess, and M. E. Kooi
Identifying vulnerable carotid plaques by noninvasive imaging
Neurology,
June 10, 2008;
70(24_Part_2):
2401 - 2409.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H.F. Rudd, K. S. Myers, S. Bansilal, J. Machac, C. A. Pinto, C. Tong, A. Rafique, R. Hargeaves, M. Farkouh, V. Fuster, et al.
Atherosclerosis Inflammation Imaging with 18F-FDG PET: Carotid, Iliac, and Femoral Uptake Reproducibility, Quantification Methods, and Recommendations
J. Nucl. Med.,
June 1, 2008;
49(6):
871 - 878.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nahrendorf, H. Zhang, S. Hembrador, P. Panizzi, D. E. Sosnovik, E. Aikawa, P. Libby, F. K. Swirski, and R. Weissleder
Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis
Circulation,
January 22, 2008;
117(3):
379 - 387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Hartung, A. Petrov, N. Haider, S. Fujimoto, F. Blankenberg, A. Fujimoto, R. Virmani, F. D. Kolodgie, H. W. Strauss, and J. Narula
Radiolabeled Monocyte Chemotactic Protein 1 for the Detection of Inflammation in Experimental Atherosclerosis
J. Nucl. Med.,
November 1, 2007;
48(11):
1816 - 1821.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Gibbons, P. A. Araoz, and E. E. Williamson
The Year in Cardiac Imaging
J. Am. Coll. Cardiol.,
September 4, 2007;
50(10):
988 - 1003.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Tahara, H. Kai, H. Nakaura, M. Mizoguchi, M. Ishibashi, H. Kaida, K. Baba, N. Hayabuchi, and T. Imaizumi
The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose positron emission tomography
Eur. Heart J.,
September 2, 2007;
28(18):
2243 - 2248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H.F. Rudd, K. S. Myers, S. Bansilal, J. Machac, A. Rafique, M. Farkouh, V. Fuster, and Z. A. Fayad
18Fluorodeoxyglucose Positron Emission Tomography Imaging of Atherosclerotic Plaque Inflammation Is Highly Reproducible: Implications for Atherosclerosis Therapy Trials
J. Am. Coll. Cardiol.,
August 28, 2007;
50(9):
892 - 896.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. Jaffer, P. Libby, and R. Weissleder
Molecular Imaging of Cardiovascular Disease
Circulation,
August 28, 2007;
116(9):
1052 - 1061.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H.F. Rudd, J. Machac, and Z. A. Fayad
Simvastatin and Plaque Inflammation
J. Am. Coll. Cardiol.,
May 15, 2007;
49(19):
1991 - 1991.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kai, N. Tahara, M. Ishibashi, and T. Imaizumi
Reply
J. Am. Coll. Cardiol.,
May 15, 2007;
49(19):
1991 - 1992.
[Full Text]
[PDF]
|
 |
|
|